{
    "Trade/Device Name(s)": [
        "Gentian Cystatin C Immunoassay"
    ],
    "Submitter Information": "Gentian AS c/o Dr. Ronald Leonardi, President of R & R Registrations",
    "510(k) Number": "K071388",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003503"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NDY"
    ],
    "Summary Letter Date": "October 05, 2007",
    "Summary Letter Received Date": "October 09, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cystatin C"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Modular P",
        "Architect ci8200",
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Particle enhanced turbidimetric immunoassay (PETIA)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Gentian Cystatin C Immunoassay using PETIA technology for measuring cystatin C in serum and plasma to aid in renal disease diagnosis.",
    "Indications for Use Summary": "In vitro diagnostic test for quantitative determination of cystatin C in human serum and plasma, used in the diagnosis and treatment of renal diseases.",
    "fda_folder": "Clinical Chemistry"
}